Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Harte Hanks (HHS) Change in Receivables (2016 - 2025)

Harte Hanks (HHS) has disclosed Change in Receivables for 16 consecutive years, with -$3.1 million as the latest value for Q3 2025.

  • On a quarterly basis, Change in Receivables fell 181.52% to -$3.1 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$5.0 million, a 225.15% decrease, with the full-year FY2024 number at -$2.4 million, up 57.82% from a year prior.
  • Change in Receivables was -$3.1 million for Q3 2025 at Harte Hanks, down from $272000.0 in the prior quarter.
  • In the past five years, Change in Receivables ranged from a high of $7.2 million in Q1 2022 to a low of -$6.8 million in Q4 2022.
  • A 5-year average of -$267263.2 and a median of -$503000.0 in 2023 define the central range for Change in Receivables.
  • Biggest YoY gain for Change in Receivables was 865.81% in 2024; the steepest drop was 1807.19% in 2024.
  • Harte Hanks' Change in Receivables stood at -$1.6 million in 2021, then crashed by 326.17% to -$6.8 million in 2022, then soared by 72.81% to -$1.8 million in 2023, then tumbled by 45.38% to -$2.7 million in 2024, then decreased by 17.51% to -$3.1 million in 2025.
  • Per Business Quant, the three most recent readings for HHS's Change in Receivables are -$3.1 million (Q3 2025), $272000.0 (Q2 2025), and $497000.0 (Q1 2025).